الرئيسية › سرطان البروستاتا › ويسكونسن › Madison
التجارب السريرية لـ سرطان البروستاتا في Madison، WI
29 دراسات لـ سرطان البروستاتا تبحث عن مشاركين في مواقع داخل وحول Madison (ضمن نطاق 30 ميلًا تقريبًا). افتح الدراسة لمعرفة من يمكنه المشاركة وكيفية التواصل مع فريق الدراسة.
النص الرسمي للدراسة (بالإنجليزية)
تبحث عن مشاركين لدراسة؟ أبرزها في أعلى الصفحة — $99 لمدة 30 يومًا →
The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)
جارٍ التسجيلالمرحلة 1/2
- University of Wisconsin Carbone Cancer Center, Madison
Testing the Addition of Docetaxel (Chemotherapy) to the Usual Treatment (Hormonal Therapy and Apalutamide) for Metastatic Prostate Cancer, ASPIRE Trial
جارٍ التسجيلالمرحلة 3
- William S Middleton VA Medical Center, Madison
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
جارٍ التسجيلدراسة رصديةمرحباً بالمتطوعين الأصحاء
- William S Middleton VA Medical Center, Madison
- University of Wisconsin Carbone Cancer Center - Eastpark Medical Center, Madison
- University of Wisconsin Carbone Cancer Center - University Hospital, Madison
PET/CT Characterization of Treatment Resistance
جارٍ التسجيل
- University of Wisconsin, Madison
This Study Will Explore Whether a Combination of the Investigational Drug Mevrometostat (PF-06821497) and Enzalutamide Will Work Better Than Taking Enzalutamide Alone in Participants With mCSPC Who Are ARPI naïve.
جارٍ التسجيلالمرحلة 3
- University of Wisconsin Carbone Cancer Center - Eastpark Medical Center, Madison
- University of Wisconsin Carbone Cancer Center - University Hospital, Madison
High Dose Testosterone for ATM, CDK12 or CHEK2 Altered Prostate Cancers
جارٍ التسجيلالمرحلة 2
- William S. Middleton Memorial Veterans Hospital, Madison, WI, Madison
Carboplatin or Olaparib for BRcA Deficient Prostate Cancer
جارٍ التسجيلالمرحلة 2
- William S. Middleton Memorial Veterans Hospital, Madison, WI, Madison
A Clinical Study of Ifinatamab Deruxtecan (I-DXd) in People With Metastatic Prostate Cancer (MK-2400-001)
جارٍ التسجيلالمرحلة 3
- University Hospital and UW Health Clinics ( Site 0065), Madison
MDRT in Prostate Cancer Treated With Long-term Androgen Deprivation Therapy in the STAMPEDE Trial (METANOVA)
جارٍ التسجيلالمرحلة 2
- Carbone Cancer Center University of Wisconsin-Madison, Madison
Positron Emission Tomography Using 64Cu-SAR-bisPSMA in Participants With High-risk Prostate Cancer Prior to Radical Prostatectomy
جارٍ التسجيلالمرحلة 3
- University of Wisconsin, Madison
Testing Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients With High Risk Prostate Cancer
جارٍ التسجيلالمرحلة 3
- University of Wisconsin Carbone Cancer Center - Eastpark Medical Center, Madison
- University of Wisconsin Carbone Cancer Center - University Hospital, Madison
A Phase 2 Study to Evaluate the Effects of ASP5541 in Participants With Prostate Cancer
جارٍ التسجيلالمرحلة 2
- UW Health Carbone Cancer Center, Madison
COMPASS Study for Metastatic Castration-resistant Prostate Cancer
جارٍ التسجيلدراسة رصدية
- University of Wisconsin Carbone Cancer Center, Madison
A Study of Talazoparib With or Without Enzalutamide in People With Prostate Cancer Who Have Previously Received Abiraterone Acetate or Darolutamide
جارٍ التسجيلالمرحلة 2
- University of Wisconsin Carbone Cancer Center-Madison, Madison
Treating Prostate Cancer That Has Come Back After Surgery With Apalutamide and Targeted Radiation Based on PET Imaging
جارٍ التسجيلالمرحلة 3
- William S Middleton VA Medical Center, Madison
- University of Wisconsin Carbone Cancer Center - Eastpark Medical Center, Madison
- University of Wisconsin Carbone Cancer Center - University Hospital, Madison
FOG-001 in Locally Advanced or Metastatic Solid Tumors
جارٍ التسجيلالمرحلة 1/2
- University of Wisconsin, Carbone Cancer Center, Madison
Study of JANX007 in Subjects With Metastatic Castration-Resistant Prostate Cancer (ENGAGER-PSMA-01)
جارٍ التسجيلالمرحلة 1
- University of Wisconsin Carbone Cancer Center, Madison
Impact of DNA Repair Pathway Alterations on Sensitivity to Radium-223 in Bone Metastatic Castration-resistant Prostate Cancer
جارٍ التسجيلدراسة رصدية
- University of Wisconsin-Madison, Madison
Docetaxel to Androgen Receptor Pathway Inhibitors in Patients With Metastatic Castration Sensitive Prostate Cancer and Suboptimal PSA Response
جارٍ التسجيلالمرحلة 3
- University of Wisconsin Carbone Cancer Center - Eastpark Medical Center, Madison
- University of Wisconsin Carbone Cancer Center - University Hospital, Madison
Testing the Safety and Effectiveness of Radiation-based Treatment (Lutetium Lu 177 Dotatate) for Metastatic Prostate Cancer That Has Neuroendocrine Cells
جارٍ التسجيلالمرحلة 2
- University of Wisconsin Carbone Cancer Center - Eastpark Medical Center, Madison
- University of Wisconsin Carbone Cancer Center - University Hospital, Madison
A Clinical Study of KTX-2001 in Subjects With Metastatic Castration-Resistant Prostate Cancer (STRIKE-001)
جارٍ التسجيلالمرحلة 1
- University of Wisconsin, Madison
Study of ORIC-944 in Patients With Metastatic Prostate Cancer
جارٍ التسجيلالمرحلة 1
- University of Wisconsin Carbone Cancer Center, Madison
Using FAPI PET/MRI to Evaluate Prostate Cancer
جارٍ التسجيلالمرحلة 2
- University of Wisconsin, Madison
International Registry for Men With Advanced Prostate Cancer (IRONMAN)
جارٍ التسجيلدراسة رصدية
- University of Wisconsin Carbone Cancer Center, Madison
Veterans Affairs Seamless Phase II/III Randomized Trial of STAndard Systemic theRapy With or Without PET-directed Local Therapy for Oligometastatic pRosTate Cancer
جارٍ التسجيلالمرحلة 2/3
- William S. Middleton Memorial Veterans Hospital, Madison, WI, Madison
Novel ACK1 Inhibitor (R)-9b in Patients With Prostate Cancer
جارٍ التسجيلالمرحلة 1
- University of Wisconsin Carbone Cancer Center (UWCCC) - Cancer Connect, Madison
Trial of pTVG-HP+Nivo+Targeted Ablation of Resistant Lesions in Non-Castrate RecurrentOMPC
جارٍ التسجيلالمرحلة 1
- University of Wisconsin - Madison, Madison
Effect on Body Movement and Mental Skills in Patients Who Received Gadolinium-based Contrast Media for Magnetic Resonance Examination Multiple Times Within 5 Years
جارٍ التسجيلالمرحلة 4
- University of Wisconsin, Madison
ARCTIC: Liquid Biomarkers in the Prospective Androgen Receptor Signaling Inhibitors (ARSI) Resistance Clinical Trials
جارٍ التسجيلدراسة رصدية
- University of Wisconsin-Madison, Madison
تجارب سرطان البروستاتا في مدن أخرى
- New York City, NY103 دراسات
- Houston, TX76 دراسات
- Los Angeles, CA61 دراسات
- Boston, MA59 دراسات
- St. Louis, MO46 دراسات
- Chicago, IL45 دراسات
- San Francisco, CA45 دراسات
- Philadelphia, PA44 دراسات
- Baltimore, MD43 دراسات
- Nashville, TN42 دراسات
- Seattle, WA42 دراسات
- Washington, DC38 دراسات
دراسات أخرى في Madison
- سرطان القولون والمستقيم22 دراسات
- سرطان الثدي22 دراسات
- السرطان النقيلي21 دراسات
- سرطان الرئة غير صغير الخلايا16 دراسات
- ابيضاض الدم النقوي الحاد16 دراسات
- ميلانوما15 دراسات
- السرطان (جميع الأنواع)14 دراسات
- سرطان المبيض13 دراسات
- سرطان المعدة11 دراسات
- سرطان الرئة10 دراسات
- سرطان البنكرياس10 دراسات
- الورم النقوي المتعدد9 دراسات
من ClinicalTrials.gov، البيانات مستخرجة في 05/10/2026. كل دراسة تحدد معايير أهليتها الخاصة؛ فريق الدراسة هو من يحدد من يمكنه المشاركة.